Propranolol use in patients with cirrhosis and refractory ascites: A nationwide study

BACKGROUND: The impact of propranolol on patients with cirrhosis and refractory ascites is controversial. We conducted a nationwide longitudinal cohort study to compare the survival between patients with cirrhosis and refractory ascites, with and without using propranolol. METHODS: Data of patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Yen-Chun, Li, Yun-Da, Lu, Chia-Ming, Huang, Wei-Chun, Kao, Sung-Shuo, Chen, Wen-Chi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9007076/
https://www.ncbi.nlm.nih.gov/pubmed/35295067
http://dx.doi.org/10.4103/sjg.sjg_586_21

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9007076/
https://www.ncbi.nlm.nih.gov/pubmed/35295067
http://dx.doi.org/10.4103/sjg.sjg_586_21

Ejemplares similares